InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

April 1, 2025

Conditions
Lung Cancer
Interventions
DEVICE

BioSpy System

One arm only - in all eligible study patients, the study device will be used. In patients with suspicion of lung cancer a bronchoscope will be inserted to navigate to the lesion where a biopsy sample will be taken for histology analysis. In the current trial, the device will be used to perform electrophysiological measurements in the lesion during bronchoscopic biopsy procedure.

Trial Locations (2)

4019

RECRUITING

Royal Brisbane and Women's Hospital, Brisbane

92350

RECRUITING

Marie-Lannelongue Hospital, Le Plessis-Robinson

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sensome

INDUSTRY

NCT06380361 - InvestigatioN of a Smart Probe for Lung lEsion Characterization Using Impedance Technology | Biotech Hunter | Biotech Hunter